We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > advanced GIST

News List

First patient dosed for Phase I/II trial of avapritinib in advanced GIST biospectrumasia
August 26, 2019
CStone announces on a registrational bridging study in China which includes a Phase I dose-escalation study and Phase II dose-expansion study to evaluate safety, pharmacokinetics and efficacy of avapritinib in patients with metastatic gastrointestinal str
CStone announces first patient dosed in China with avapritinib for advanced GIST biospectrumasia
July 10, 2019
Global Phase III clinical trial to evaluate the safety and efficacy of avapritinib as a 3rd or 4th line treatment for patients with gastrointestinal stromal tumours (GIST), in comparison with regorafenib